| __timestamp | BioMarin Pharmaceutical Inc. | Johnson & Johnson |
|---|---|---|
| Wednesday, January 1, 2014 | 461543000 | 8494000000 |
| Thursday, January 1, 2015 | 634806000 | 9046000000 |
| Friday, January 1, 2016 | 661905000 | 9095000000 |
| Sunday, January 1, 2017 | 610753000 | 10554000000 |
| Monday, January 1, 2018 | 696328000 | 10775000000 |
| Tuesday, January 1, 2019 | 715007000 | 11355000000 |
| Wednesday, January 1, 2020 | 628116000 | 12340000000 |
| Friday, January 1, 2021 | 628793000 | 14277000000 |
| Saturday, January 1, 2022 | 649606000 | 14135000000 |
| Sunday, January 1, 2023 | 746773000 | 15048000000 |
| Monday, January 1, 2024 | 747184000 | 17232000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical landscape, innovation is the lifeblood of progress. Johnson & Johnson and BioMarin Pharmaceutical Inc. are two titans in this arena, each with a distinct approach to research and development (R&D) investment. Over the past decade, Johnson & Johnson has consistently outpaced BioMarin, investing nearly 18 times more in R&D annually. From 2014 to 2023, Johnson & Johnson's R&D expenses surged by approximately 77%, peaking at $15 billion in 2023. In contrast, BioMarin's investment grew by 62%, reaching $747 million in the same year. This disparity highlights Johnson & Johnson's robust commitment to innovation, while BioMarin's focused investments reflect its strategic niche in the biotech sector. As the industry continues to advance, these investment trends will shape the future of healthcare innovation.
Who Prioritizes Innovation? R&D Spending Compared for Johnson & Johnson and Biogen Inc.
R&D Insights: How Johnson & Johnson and Ionis Pharmaceuticals, Inc. Allocate Funds
Research and Development Expenses Breakdown: Johnson & Johnson vs Alkermes plc
Johnson & Johnson or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Johnson & Johnson and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Sanofi and BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. vs Opthea Limited: Strategic Focus on R&D Spending
BioMarin Pharmaceutical Inc. vs TG Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for BioMarin Pharmaceutical Inc. and Ionis Pharmaceuticals, Inc.
BioMarin Pharmaceutical Inc. vs ADMA Biologics, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: BioMarin Pharmaceutical Inc. vs HUTCHMED (China) Limited
Research and Development Investment: BioMarin Pharmaceutical Inc. vs Dynavax Technologies Corporation